Sodium Chloride and Aldosterone Harbingers of Hypertension-Related Cardiovascular Disease

被引：6

作者：

Kotchen, Theodore A. ^{[1
]}

机构：

[1] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA

来源：

HYPERTENSION | 2009年 / 54卷 / 03期

关键词：

LEFT-VENTRICULAR HYPERTROPHY; HEART-FAILURE; EPLERENONE; SALT; ANGIOTENSIN; PRESSURE; MASS; RATS;

D O I：

10.1161/HYPERTENSIONAHA.109.136226

中图分类号：

R6 [外科学];

学科分类号：

100210 [外科学];

摘要：

引用

收藏

页码：449 / 450

页数：2

相关论文

共 11 条

[1]

Aldosterone and vascular inflammation [J].

Brown, Nancy J. .

HYPERTENSION, 2008, 51 (02) :161-167

[2]

Arterial pressure, left ventricular mass, and aldosterone in essential hypertension [J].

El-Gharbawy, AH ;

Nadig, VS ;

Kotchen, JM ;

Grim, CE ;

Sagar, KB ;

Kaldunski, M ;

Hamet, P ;

Pausova, Z ;

Gaudet, D ;

Gossard, F ;

Kotchen, TA .

HYPERTENSION, 2001, 37 (03) :845-850

[3]

Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats [J].

Endemann, DH ;

Touyz, RM ;

Iglarz, M ;

Savoia, C ;

Schiffrin, EL .

HYPERTENSION, 2004, 43 (06) :1252-1257

[4]

Independent Relations of Left Ventricular Structure With the 24-Hour Urinary Excretion of Sodium and Aldosterone [J].

Jin, Yu ;

Kuznetsova, Tatiana ;

Maillard, Marc ;

Richart, Tom ;

Thijs, Lutgarde ;

Bochud, Murielle ;

Herregods, Marie-Christine ;

Burnier, Michel ;

Fagard, Robert ;

Staessen, Jan A. .

HYPERTENSION, 2009, 54 (03) :489-U95

[5]

Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt [J].

Lea, William B. ;

Kwak, Eun Soo ;

Luther, James M. ;

Fowler, Susan M. ;

Wang, Zuofei ;

Ma, Ji ;

Fogo, Agnes B. ;

Brown, Nancy J. .

KIDNEY INTERNATIONAL, 2009, 75 (09) :936-944

[6]

High sodium intake modulates left ventricular mass in patients with G expression of +1675 G/A angiotensin II receptor type 2 gene [J].

Ott, Christian ;

Titze, Stephanie I. ;

Schwarz, Thomas K. ;

Kreutz, Reinhold ;

Hilgers, Karl F. ;

Schmidt, Bernhard M. W. ;

Schlaich, Markus P. ;

Schmieder, Roland E. .

JOURNAL OF HYPERTENSION, 2007, 25 (08) :1627-1632

[7]

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [J].

Pitt, B ;

Remme, W ;

Zannad, F ;

Neaton, J ;

Martinez, F ;

Roniker, B ;

Bittman, R ;

Hurley, S ;

Kleiman, J ;

Gatlin, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1309-1321

[8]

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy - The 4E-left ventricular hypertrophy study [J].

Pitt, B ;

Reichek, N ;

Willenbrock, R ;

Zannad, F ;

Phillips, RA ;

Roniker, B ;

Kleiman, J ;

Krause, S ;

Burns, D ;

Williams, GH .

CIRCULATION, 2003, 108 (15) :1831-1838

[9]

The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].

Pitt, B ;

Zannad, F ;

Remme, WJ ;

Cody, R ;

Castaigne, A ;

Perez, A ;

Palensky, J ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717

[10]

Salt-induced cardiac hypertrophy is independent of blood pressure and endothelin in obese, heart failure-prone SHHF rats [J].

Radin, M. Judith ;

Holycross, Bethany J. ;

Hoepf, Toni M. ;

McCune, Sylvia A. .

CLINICAL AND EXPERIMENTAL HYPERTENSION, 2008, 30 (07) :541-552